Tags

Type your tag names separated by a space and hit enter

Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.
Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):216-225.IJ

Abstract

Background & objectives

An outbreak of respiratory illness of unknown aetiology was reported from Hubei province of Wuhan, People's Republic of China, in December 2019. The outbreak was attributed to a novel coronavirus (CoV), named as severe acute respiratory syndrome (SARS)-CoV-2 and the disease as COVID-19. Within one month, cases were reported from 25 countries. In view of the novel viral strain with reported high morbidity, establishing early countrywide diagnosis to detect imported cases became critical. Here we describe the role of a countrywide network of VRDLs in early diagnosis of COVID-19.

Methods

The Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV), Pune, established screening as well as confirmatory assays for SARS-CoV-2. A total of 13 VRDLs were provided with the E gene screening real-time reverse transcription-polymerase chain reaction (rRT-PCR) assay. VRDLs were selected on the basis of their presence near an international airport/seaport and their past performance. The case definition for testing included all individuals with travel history to Wuhan and symptomatic individuals with travel history to other parts of China. This was later expanded to include symptomatic individuals returning from Singapore, Japan, Hong Kong, Thailand and South Korea.

Results

Within a week of standardization of the test at NIV, all VRDLs could initiate testing for SARS-CoV-2. Till February 29, 2020, a total of 2,913 samples were tested. This included both 654 individuals quarantined in the two camps and others fitting within the case definition. The quarantined individuals were tested twice - at days 0 and 14. All tested negative on both occasions. Only three individuals belonging to different districts in Kerala were found to be positive.

Interpretation & conclusions

Sudden emergence of SARS-CoV-2 and its potential to cause a pandemic posed an unsurmountable challenge to the public health system of India. However, concerted efforts of various arms of the Government of India resulted in a well-coordinated action at each level. India has successfully demonstrated its ability to establish quick diagnosis of SARS-CoV-2 at NIV, Pune, and the testing VRDLs.

Authors+Show Affiliations

Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.Influenza Group, ICMR-National Institute of Virology, Pune, India.Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, India.Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, India.Influenza Group, ICMR-National Institute of Virology, Pune, India.Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.ICMR-National Institute of Virology Kerala Unit, Alappuzha, Kerala, India.Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India.ICMR-National Institute of Virology Bangalore Field Unit, Bengaluru, Karnataka, India.Department of Microbiology, Kasturba Hospital for Infectious Diseases, Mumbai, India.Department of Virology, King Institute of Preventive Medicine & Research, Chennai, Tamil Nadu, India.ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, West Bengal, India.Department of Microbiology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India.Department of Microbiology, Gandhi Medical College & Hospital, Secunderabad, Telangana, India.Bangalore Medical College & Research Institute, Bengaluru, Karnataka, India.Department of Microbiology, Indira Gandhi Government Medical College & Hospital, Nagpur, Maharashtra, India.Department of Microbiology, Byramjee Jeejeebhoy Medical College, Ahmedabad, Gujarat, India.Department of Microbiology, Gauhati Medical College & Hospital, Guwahati, Assam, India.Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.ICMR-National Institute of Virology Kerala Unit, Alappuzha, Kerala, India.ICMR-National Institute of Virology Bangalore Field Unit, Bengaluru, Karnataka, India.Department of Microbiology, Kasturba Hospital for Infectious Diseases, Mumbai, India.Department of Virology, King Institute of Preventive Medicine & Research, Chennai, Tamil Nadu, India.ICMR-National Institute of Cholera & Enteric Diseases, Kolkata, West Bengal, India.Department of Microbiology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India.Department of Microbiology, Gandhi Medical College & Hospital, Secunderabad, Telangana, India.Bangalore Medical College & Research Institute, Bengaluru, Karnataka, India.Department of Microbiology, Indira Gandhi Government Medical College & Hospital, Nagpur, Maharashtra, India.Department of Microbiology, Byramjee Jeejeebhoy Medical College, Ahmedabad, Gujarat, India.Department of Microbiology, Gauhati Medical College & Hospital, Guwahati, Assam, India.Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India.Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India.Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.Department of Health Research, Ministry of Health & Family Welfare, Government of India, New Delhi, India.Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.ICMR-National Institute of Virology, Pune, India.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32242875

Citation

Gupta, Nivedita, et al. "Laboratory Preparedness for SARS-CoV-2 Testing in India: Harnessing a Network of Virus Research & Diagnostic Laboratories." The Indian Journal of Medical Research, vol. 151, no. 2 & 3, 2020, pp. 216-225.
Gupta N, Potdar V, Praharaj I, et al. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020;151(2 & 3):216-225.
Gupta, N., Potdar, V., Praharaj, I., Giri, S., Sapkal, G., Yadav, P., Choudhary, M. L., Dar, L., Sugunan, A. P., Kaur, H., Munivenkatappa, A., Shastri, J., Kaveri, K., Dutta, S., Malhotra, B., Jain, A., Nagamani, K., Shantala, G. B., Raut, S., ... Abraham, P. (2020). Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. The Indian Journal of Medical Research, 151(2 & 3), 216-225. https://doi.org/10.4103/ijmr.IJMR_594_20
Gupta N, et al. Laboratory Preparedness for SARS-CoV-2 Testing in India: Harnessing a Network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020 Feb & Mar;151(2 & 3):216-225. PubMed PMID: 32242875.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. AU - Gupta,Nivedita, AU - Potdar,Varsha, AU - Praharaj,Ira, AU - Giri,Sidhartha, AU - Sapkal,Gajanan, AU - Yadav,Pragya, AU - Choudhary,Manohar Lal, AU - Dar,Lalit, AU - Sugunan,A P, AU - Kaur,Harmanmeet, AU - Munivenkatappa,Ashok, AU - Shastri,Jayanthi, AU - Kaveri,Krishnasamy, AU - Dutta,Shanta, AU - Malhotra,Bharti, AU - Jain,Amita, AU - Nagamani,Kammilli, AU - Shantala,G B, AU - Raut,Sharmila, AU - Vegad,M M, AU - Sharma,Ajanta, AU - Choudhary,Aashish, AU - Brijwal,Megha, AU - Balakrishnan,Anukumar, AU - Manjunatha,Jayaswamy, AU - Pathak,Manish, AU - Srinivasan,Sivasubramanian, AU - Banu,Hasina, AU - Sharma,Himanshu, AU - Jain,Parul, AU - Sunita,Pakalpati, AU - Ambica,R, AU - Fageria,Babita, AU - Patel,Disha, AU - Rajbongshi,Gitika, AU - Vijay,Neetu, AU - Narayan,Jitendra, AU - Aggarwal,Neeraj, AU - Nagar,Anu, AU - Gangakhedkar,Raman R, AU - Abraham,Priya, PY - 2020/4/4/pubmed PY - 2020/5/7/medline PY - 2020/4/4/entrez KW - Virus Research and Diagnostic Laboratory KW - diagnosis KW - preparedness KW - quality control KW - quarantine KW - severe acute respiratory syndrome-CoV-2 KW - COVID-19 SP - 216 EP - 225 JF - The Indian journal of medical research JO - Indian J Med Res VL - 151 IS - 2 & 3 N2 - Background & objectives: An outbreak of respiratory illness of unknown aetiology was reported from Hubei province of Wuhan, People's Republic of China, in December 2019. The outbreak was attributed to a novel coronavirus (CoV), named as severe acute respiratory syndrome (SARS)-CoV-2 and the disease as COVID-19. Within one month, cases were reported from 25 countries. In view of the novel viral strain with reported high morbidity, establishing early countrywide diagnosis to detect imported cases became critical. Here we describe the role of a countrywide network of VRDLs in early diagnosis of COVID-19. Methods: The Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV), Pune, established screening as well as confirmatory assays for SARS-CoV-2. A total of 13 VRDLs were provided with the E gene screening real-time reverse transcription-polymerase chain reaction (rRT-PCR) assay. VRDLs were selected on the basis of their presence near an international airport/seaport and their past performance. The case definition for testing included all individuals with travel history to Wuhan and symptomatic individuals with travel history to other parts of China. This was later expanded to include symptomatic individuals returning from Singapore, Japan, Hong Kong, Thailand and South Korea. Results: Within a week of standardization of the test at NIV, all VRDLs could initiate testing for SARS-CoV-2. Till February 29, 2020, a total of 2,913 samples were tested. This included both 654 individuals quarantined in the two camps and others fitting within the case definition. The quarantined individuals were tested twice - at days 0 and 14. All tested negative on both occasions. Only three individuals belonging to different districts in Kerala were found to be positive. Interpretation & conclusions: Sudden emergence of SARS-CoV-2 and its potential to cause a pandemic posed an unsurmountable challenge to the public health system of India. However, concerted efforts of various arms of the Government of India resulted in a well-coordinated action at each level. India has successfully demonstrated its ability to establish quick diagnosis of SARS-CoV-2 at NIV, Pune, and the testing VRDLs. SN - 0971-5916 UR - https://www.unboundmedicine.com/medline/citation/32242875/Laboratory_preparedness_for_SARS_CoV_2_testing_in_India:_Harnessing_a_network_of_Virus_Research_&_Diagnostic_Laboratories_ DB - PRIME DP - Unbound Medicine ER -